Authors:
Pagano R.
Institution
Dr. R. Pagano, Private Consulting Suites, Royal Women's Hospital, 285
Cardigan Street, Carlton, Vic. 3053; Australia.
Title:
Vulvar vestibulitis syndrome: An often unrecognized cause of dyspareunia.
(1999-3055a)
Source:
Australian and New Zealand Journal of Obstetrics and Gynaecology. Vol 39(1)
(pp9-83), 1999.
Abstract:
Vulvar vestibulitis syndrome (VVS) is an easily identifiable cause of entry
dyspareunia. The aetiology is unknown although there is a strong association
with Candida infection. The condition represents a focal area of hyperaesthesia
within the vulvar vestibule. A management protocol for patients with this
condition is presented; 230 patients with VVS were managed and followed-up over
a 5-year period. Spontaneous resolution or improvement occurred in 21% of
patients following initial explanation and use of simple local measures. In 21%,
there were positive Candida cultures and long-term antifungal therapy resulted
in a 71% cure. In Candida-negative patients, low-dose amitriptyline was used (up
to 75 mg daily) with a 60% positive response rate. Carbamazepine was of little
benefit (13% response). Surgical vestibulectomy was offered when conservative
measures failed and this was performed in 22 patients (10%) with a beneficial
result in 20 patients (91%).
Related Medical Abstracts - Click on the paper title:-
Please click on the required question.